Bloomberg: “Osteoporosis drug sales have reaped billions. Is it a classic case of disease-mongering?”
“Drugs to increase bone strength that have reaped billions of dollars in sales aren’t worth the cost and the risk of side effects, researchers argue in apublished in the . ”